Web-based lifestyle application
Web-based lifestyle application has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Jan 13, 2026: “Web-based lifestyle application as support for secondary prevention in patients with intermittent claudication”.
1 paper studies it3 findingsUpdated
See all 1 papers on web-based lifestyle application
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“No significant differences in variables walking distance, ABI, blood pressure or BMI were observed between the groups.”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Skånes universitetssjukhus
- Human trial1
Studies in people
1 study gave web-based lifestyle application to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on walking distance no change: Has no effect on ankle-brachial index | Randomized trial3 months | 18 peopleBothMean age 73 yearsOlder adults; Patients with intermittent claudication; within-intervention-group improvement | VASA. Zeitschrift fur Gefasskrankheiten, Jan 13, 2026 |
What did studies of web-based lifestyle application find?
3Studies of web-based lifestyle application measured 3 outcomes: ankle-brachial index, walking distance and quality of life.
Ankle-brachial index
no changein humans1
1 study
Ankle-brachial index
no changein humans1
Web-based lifestyle application showed no clear effect on ankle-brachial index in humans (Patients with intermittent claudication; intervention versus control).
“No significant differences in variables walking distance, ABI, blood pressure or BMI were observed between the groups.”
Human trialPatients with intermittent claudication; intervention versus control3 months52.9% womensn = 34
VASA. Zeitschrift fur Gefasskrankheiten
Walking distance
no changein humans1
1 study
Walking distance
no changein humans1
Web-based lifestyle application showed no clear effect on walking distance in humans (Patients with intermittent claudication; intervention versus control).
“No significant differences in variables walking distance, ABI, blood pressure or BMI were observed between the groups.”
Human trialPatients with intermittent claudication; intervention versus control3 months52.9% womensn = 34
VASA. Zeitschrift fur Gefasskrankheiten
Quality of life
upin humans1
1 study
Quality of life
upin humans1
Web-based lifestyle application improves quality of life in humans (Patients with intermittent claudication; within-intervention-group improvement).
“QoL were improved in the intervention group (p=.049)”
Human trialPatients with intermittent claudication; within-intervention-group improvement3 monthsn = 18
VASA. Zeitschrift fur Gefasskrankheiten